Latest Breaking News On - Manufacturing trivalent filovirus - Page 1 : comparemela.com

Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results

Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

South africaUnited statesUnited kingdomChristopherj schaberUs congressOur public health solutionsDevelopment authorityPrnewswire soligenix incExchange commissionDefense threat reduction agencySoligenix incOffice of orphan products developmentNational institute of allergyDrug administrationBiomedical advanced researchEuropean medicines agency

Soligenix extends patent protection for its filovirus vaccine platform to the UK and South Africa

Soligenix announced it has received notice of intent to grant additional patents based on its patent application in the UK and South Africa.

United statesUnited kingdomSouth africaAxel lehrerOreola doniniSmall business innovation researchNational institute of healthUniversity of hawaiiCompany public health solutionsJohna burns school of medicineManufacturing trivalent filovirusAssociate professorSenior vice presidentChief scientific officerPublic health solutionsNational institute

Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa

Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomEquatorial guineaSouth africaUnited statesWhite houseDistrict of columbiaOreola doniniAxel lehrerDevelopment authoritySmall business innovation researchUs congressExchange commissionBiomedical advanced researchJohna burns school of medicineNational institute of allergyCompany public health solutions

Soligenix vaccine patent application advances

Soligenix of Princeton received a notice of allowance for its patent application titled “Compositions and Methods of Manufacturing Trivalent Filovirus Vaccines.”

United statesOreola doniniMarburg marburgvirusAxel lehrerTrademark officeUniversity of hawaiiUniversity of hawaiSoligenix incNational institute of healthSmall business innovation researchJohna burns school of medicineManufacturing trivalent filovirusNational institute